- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.12.25 | Envue Medical passt langfristigen Anreizplan an israelisches Steuerrecht an | 2 | Investing.com Deutsch | ||
| 23.12.25 | ENvue Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 18.12.25 | UK adds ENvue Medical's UroShield kit to NHS drug tariff | 2 | Investing.com | ||
| 18.12.25 | ENvue Medical, Inc.: ENvue Medical, Formerly NanoVibronix, UroShield Kit Secures Reimbursement in the UK | 1 | GlobeNewswire (USA) | ||
| 12.12.25 | NanoVibronix feeds into new focus on ENvue enteral system with rebrand | 4 | FiercePharma | ||
| 12.12.25 | NanoVibronix to rebrand as ENvue Medical, trade under FEED symbol | 3 | Investing.com | ||
| 12.12.25 | NanoVibronix, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.12.25 | NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and 'FEED' | 155 | Business Wire | New ticker symbol, "FEED" will begin trading on the Nasdaq at the open of the market on December 12, 2025
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) ("NanoVibronix" or the "Company")... ► Artikel lesen | |
| ENVUE MEDICAL Aktie jetzt für 0€ handeln | |||||
| 05.12.25 | NanoVibronix, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 19.11.25 | NanoVibronix to rebrand with focus on ENvue tech, seek alternatives for legacy products | 1 | MassDevice | ||
| 19.11.25 | NanoVibronix issues letter to shareholders | 1 | Seeking Alpha | ||
| 19.11.25 | NanoVibronix to rebrand as ENvue Medical, focuses on feeding tube tech | 1 | Investing.com | ||
| 19.11.25 | NanoVibronix, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.11.25 | NanoVibronix, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 30.10.25 | NanoVibronix, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 17.09.25 | NanoVibronix, Inc. - 8-K, Current Report | 15 | SEC Filings | ||
| 16.09.25 | NanoVibronix prices $2M registered direct offering | 14 | Seeking Alpha | ||
| 16.09.25 | NanoVibronix raises $2 million in registered direct offering | 1 | Investing.com | ||
| 16.09.25 | NanoVibronix stock tumbles after share resale registration | 1 | Investing.com | ||
| 15.09.25 | NanoVibronix files to sell 1.35M shares of common stock for holders | 1 | Seeking Alpha |
1 2 3 Weiter >>
47 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 46,310 | +0,46 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| BECTON DICKINSON | 174,10 | -0,94 % | Stifel raises Becton Dickinson stock price target to $215 from $210 | ||
| NUGEN MEDICAL DEVICES | 0,023 | +24,18 % | NuGen Medical: Kurs explodiert nach wichtiger News! | ||
| SPINEWAY | 0,188 | 0,00 % | Spineway: Revenue growth in the third quarter | Ecully, October 14, 2025 - 6:30 p.m. SPINEWAYRevenue growth in the third quarter In thousands of euros20252024Change as a %Q3 revenue3,0452,575 +18%Q2 revenue2,7453,465-21% Q1 revenue2,8283,070-8%9M... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| LIFEWARD | 0,635 | -2,52 % | Lifeward-Aktionäre genehmigen Aktienzusammenlegung und Satzungsänderungen | ||
| NUWELLIS, INC | 2,020 | -1,94 % | Nuwellis receives patent for blood filtration safety mechanisms | ||
| LOGICMARK | - | - | LogicMark, Inc. Announces Third Quarter 2025 Results | LOUISVILLE, Ky., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc.?(OTC: LGMKD) (the Company), a provider of personal safety and emergency response systems (PERS), health communications devices, and... ► Artikel lesen | |
| GLUCOTRACK | 3,860 | +1,85 % | GlucoTrack, Inc.: Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights | On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device... ► Artikel lesen | |
| BONE BIOLOGICS | 1,570 | +2,61 % | BONE BIOLOGICS CORPORATION: Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months | BURLINGTON, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen | |
| MANGOCEUTICALS | 0,879 | +3,68 % | Mangoceuticals, Inc.: Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs | Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company") is issuing the following clarification regarding its press release issued earlier... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,180 | -2,59 % | EILMELDUNG: Fresenius Medical Care-Aktie im freien Fall - Anleger fliehen aus dem Wert! | ||
| FRESENIUS | 48,970 | +1,09 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,510 | -2,85 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 42,640 | +0,71 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen |
Das Unternehmen ENVUE MEDICAL INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -1,32 % bei einem Aktienkurs von 2,250 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ENVUE MEDICAL INC finden Sie auf Wallstreet Online.